Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Sunday
May 08
10:30 - 11:30
Mini-Oral Theatre 1
11: Intra-fraction motion management
Helen Grimes, United Kingdom;
Sara Abdollahi, Switzerland
2280
Mini-Oral
Physics
Using the ICD lead as a tracking surrogate for cardiac radioablation: impact of cardiac motion
Louis Rigal, France
MO-0474

Abstract

Using the ICD lead as a tracking surrogate for cardiac radioablation: impact of cardiac motion
Authors:

Louis Rigal1, Julien Bellec2, Aurélien Hervouin2, Mathieu Lederlin3, Karim Benali4, Raphaël Martins5, Renaud De Crevoisier6, Antoine Simon1

1Université Rennes 1, LTSI - Inserm 1099, Rennes, France; 2CLCC Eugène Marquis, Medical Physics Department, Rennes, France; 3CHU Rennes, Radiology and Medical Imaging Department, Rennes, France; 4Saint-Etienne University Hospital, Department of Cardiology, Saint-Priest-En-Jarez, France; 5CHU Rennes, Department of Cardiology, Rennes, France; 6CLCC Eugène Marquis, Radiation Therapy Department, Rennes, France

Show Affiliations
Purpose or Objective

Cardiac radioablation is a promising application of stereotactic body radiotherapy for patients with refractory ventricular tachycardias (VT). The Implantable Cardioverter Defibrillator (ICD) lead is often used as a surrogate when using an active respiratory motion technique. However, the ICD lead and the target volume may present motion discrepancies during the cardiac cycle. These uncertainties should then be considered when defining the planning target volume. The objectives of this study were to evaluate: (i) the reliability of the ICD lead to track the target position along the cardiac cycle; (ii) the geometrical impact of these tracking uncertainties on the target volume.

Material and Methods

Contrast-enhanced breath-hold cardiac computed tomography (c4D-CT) of 16 patients were acquired and reconstructed in 10 3D images datasets. The arrhythmogenic substrate, defined as the Clinical Target Volume (CTV), was delineated on one phase of each c4D-CT dataset. The CTV was then propagated to all other phases using deformable image registration. The centroid coordinates of the propagated CTV, which were considered as the position of the CTV, were reported for each c4D-CT phase. The successive positions of the ICD lead were also reported by manually locating the tip of the ICD lead in each c4D-CT phase.

CTV and ICD lead motions discrepancies were evaluated by calculating the Mean Absolute Error (MAE) between their displacement vectors. The correlation between MAE and the ICD lead-to-CTV distance (d) was evaluated by computing the Pearson Correlation Coefficient (PCC).

To evaluate the geometrical impact of the motion discrepancies on the target volume, all phases were registered by considering the ICD lead static. A synchronization ITV (ITVsync) was then defined as the union of the propagated CTVs.

Results

MAE and d values are reported in figure 1.


The mean (min - max) MAE was of 3.2 (1.4 - 4.9) mm. The mean (min - max) d value was 66 (19 – 120) mm. No correlation was found between MAE and d (PCC = 0.28).

The CTV and ITVsync are reported in figure 2. The ITVsync represented a mean (min – max) relative increase of the CTV of 101 (39 – 151) %.


Conclusion

In cardiac radioablation of VT, large discrepancies between cardiac-induced motions of the ICD lead and CTV occur. Integrating these errors requires doubling the target volume on average.